We surveyed 1,000+ patients to uncover their perspectives about direct‑to‑patient. Read the report
Pressroom
PHIL in the Press
Read our latest news, announcements, and thought leadership.
Latest Announcements
PHIL Invests in State-of-the-Art Cash Dispense Capabilities, Expanding Direct-to-Patient Fulfillment for Pharma
Read announcementTenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program
Read announcementSprout Pharmaceuticals and PHIL Expand Their Affordable Direct-to-Patient Access Program for Addyi
Read announcementFeatured Thought Leadership
All Coverage
Drug Channels
Protecting Gross-to-Net Performance Through Single-Channel Ecosystems
Press Release
PHIL Invests in State-of-the-Art Cash Dispense Capabilities, Expanding Direct-to-Patient Fulfillment for Pharma
Press Release
Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program
Press Release
Sprout Pharmaceuticals and PHIL Expand Their Affordable Direct-to-Patient Access Program for Addyi
Fierce Pharma
The Hidden GTN Drain: Why Specialty-Lite Brands Need To Streamline The PA Process
Life Science Leader
Pharma Direct-To-Patient 2.0: From Experiment To Imperative
Ready to simplify medication access?
See how PHIL moves more patients to therapy, quickly and affordably
Take a tour of the PHIL platform and discover how we can help amplify starts, adherence, coverage, and commercial success.
Corporate Headquarters
14500 N Northsight Blvd, Suite 307, Scottsdale, AZ 85260
